The Anti-NMDA Receptor Encephalitis Foundation Newsletter

The identification of anti-NMDA receptor (NMDAR) encephalitis about 12 years ago made
it possible to recognise that some patients with rapidly progressive psychiatric symptoms
or cognitive impairment, seizures, abnormal movements, or coma of unknown cause, had
an autoimmune disease.

 




Dr. Maarten Tituler is Assistant Professor of Neurology at Erasmus Research Center, Rotterdam, Netherlands. He combines clinical work with translational rese…

 




Dr. Sander Markx is a psychiatrist at Columbia University/Precision Psychiatry which researches more modern treatments of psychiatry. He studies the genetics…

 




Using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and University of California, San Francisco (UCSF), have discovered an autoimmune disease that appears to affect men with testicular cancer.

 




An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models From…

 




Dr. Matthew Fink is the Professor and Chairman of the Department of Neurology at the Weill Cornell Medical College of Cornell University, a critical care neu…

 




Dr. Josep Dalmau is currently a professor at the Catalan Institution for Research and Advanced Studies (ICREA) Institut d’Investigacions Biomediques August P…

 




Dr. Robert Weir is a Post doctorate fellow at UT Southwestern dually trained in both Neurology and Psychiatry. Dr. Weir proposed their de novo curriculum whi…

 




Autoimmune encephalitis is one of the most rapidly growing research topics in neurology. Along with discoveries of novel antibodies associated with the disease, clinical experience and outcomes wit…

 




To evaluate the clinical characteristics, treatment outcomes, prognosis and potential risk factors of patients in East China with seizure secondary to……